BACTROBAN NASAL إسرائيل - الإنجليزية - Ministry of Health

bactroban nasal

glaxo smith kline (israel) ltd - mupirocin as calcium - ointment - mupirocin as calcium 2 %w/w - mupirocin - mupirocin - the elimination of nasal carriage of staphylococci, including methycillin-resistant staphylococus aureus (mrsa).

VENTOLIN INJECTION إسرائيل - الإنجليزية - Ministry of Health

ventolin injection

glaxo smith kline (israel) ltd - salbutamol as sulfate - solution for injection - salbutamol as sulfate 0.5 mg/ml - salbutamol - salbutamol - ventolin injection is indicated in adults.ventolin injection provides short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. it is indicated for the relief of severe bronchospasm.

AUGMENTIN ES 600 MG5 ML إسرائيل - الإنجليزية - Ministry of Health

augmentin es 600 mg5 ml

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

AUGMENTIN ES 600 MG5 ML إسرائيل - الإنجليزية - Ministry of Health

augmentin es 600 mg5 ml

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

INCRUSE ELLIPTA 55 MCG إسرائيل - الإنجليزية - Ministry of Health

incruse ellipta 55 mcg

glaxo smith kline (israel) ltd - umeclidinium as bromide - powder for inhalation - umeclidinium as bromide 55 mcg - umeclidinium bromide - incruse is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

NUCALA POWDER FOR SOLUTION FOR INJECTION إسرائيل - الإنجليزية - Ministry of Health

nucala powder for solution for injection

glaxo smith kline (israel) ltd - mepolizumab - powder for solution for injection - mepolizumab 100 mg - mepolizumab - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adult patientschronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with corticosteroids and surgery in the last 10 years do not provide adequate disease control.eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (egpa).hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.